%20LIMITED%2017-Mar-2008_files/image002.jpg){kind=small}
MIRA
INFORM REPORT
|
Report Date : |
17.03.2008 |
IDENTIFICATION
DETAILS
|
Name : |
HAMAZ PHARMACEUTICALS (PVT) LIMITED |
|
|
|
|
Registered Office : |
Amas Plaza Abdali Road Near Town
Hall, Multan |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1994 |
|
|
|
|
Com. Reg. No.: |
0032270 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture and Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
HAMAZ PHARMACEUTICALS (PVT) LIMITED
Full Address
|
Registered
Address |
|
Amas Plaza Abdali Road Near Town
Hall, Multan, Pakistan |
|
Tel |
92 (61) 4545786, 4548662 |
|
Fax |
92 (61) 4573401 |
Short Description Of Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
1994 |
|
Registration # |
0032270 |
Factory Location
|
Address |
13-K.M., Bosan Road, Multan,
Pakistan |
|
Tel # |
92 (61) 4595100, 4595108 |
|
Fax # |
92 (61) 4595109 |
Auditors
M/s Mahboob Sheikh & Company
(Chartered Accountants)
Near HBL Building, Near Auto Plaza, Dera Adda Chowk, L.M.Q. Road, Multan
Legal Status
Subject Company was established as a Private Limited Company in 1994
|
Authorized Capital |
Rs. 20,000,000/- divided into 200,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs. 20,000,000/- divided into 200,000 shares of Rs. 100/- each |
Details of Chief Executive/
Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Muhammad Zafar Iqbal Mr. Muhammad Azhar Javaid Mr. Muhammad Saeed Mr. Muhammad Saleem |
Pakistani Pakistani Pakistani Pakistani |
Amas Plaza Abdali Road Near Town Hall, Multan Amas Plaza Abdali Road Near Town Hall, Multan Amas Plaza Abdali Road Near Town Hall, Multan Amas Plaza Abdali Road Near Town Hall, Multan |
Business Business Business Business |
Chief Executive Director Director Director |
Shareholders
Names
Mr. Muhammad Zaffar Iqbal
Mr. Muhammad Azhar Javed
Mr. Muhammad Mazhar Iqbal Khan
Mr. Adnan Zafar
Mr. Sajid Mazhar
Mr. Imran Saboor
Mr. Sheikh Muhammad Saboor
Mr. Muhammad Saleem
Mrs. Yasmeen Bano
Mrs. Shehnaz Bano
Associates
A. Subsidiary
None
B. Associated Companies
(1) Drug Exchange (Pvt) Ltd, Pakistan.
(2) Progressive Agencies,
Pakistan.
(3) Bluch Enterprises, Pakistan.
(4) Epoch Pharmaceuticals,
Pakistan.
(5) Saleem Enterprises, Pakistan.
Products / Services
Manufacture & marketing of Pharmaceutical Products by its brand name of ALPHA VIRIN, AMPIMAZ, BEETOX, CARVES, CEDOX, CITALEM, CLOPREL, DIAGLIET 3H, DICLOSAK, DIOTAN 3H, ERYTAB, ESTADOL, FEXOTEL-3H, FREECOS, GASTER, HAMADAR, HAMAZOL, HAMAZONE, IBURIN, INDOCAP, LOPCIT 3H, LOTAR, MAZACLOX, MAZATRIM, MAZATRIM FORTE, MONTILAK 3H, MUSKEL, NEOPHED, NU-FLURBROFEN, PANAMAZ, PHENICHLORE, PHONAC, PHOSOQUINE, PLGROL 3H, PROME, RAMITACE 3H, SKYMOX, SLASH 3H, SUGLOW 3H, TETRAMAZ, TOPERATEC 3H, TORLIP 3H, TRASER 3H, ULTAVIT-C, ZAKULATE 3H
Number of Employees
179
Trade Suppliers (Foreign)
YANGZHOU PHARMACEUTICAL CO. LTD, CHINA.
MANGALAM DRUGS & ORGANICS LIMITED, INDIA.
SHIJIAZHUANG PHARMACEUTICAL GROUP, CHINA.
Annual Production Volume
The capacity and production of the company’s plant is indeterminable as it involves varying processes of manufacture.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
180,000,000/- (Estimated) |
Customers
Mainly in all major cities of Pakistan
Bankers
(1) Bank Al-Habib Limited, Hussain Agahi Road, Multan, Pakistan.
(Mortgage obtained PKR 115,000,000/-)
Memberships
Pakistan Pharmaceutical Manufacturers Association.(PPMA)
Multan Chamber of Commerce & Industry.(MCCI)
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 62.90 |
|
UK Pound |
1 |
Rs.126.75 |
|
Euro |
1 |
Rs. 98.35 |
Comments
Subject Company was established in 1994 and is engaged in manufacture & marketing of Pharmaceutical Products. Overall reputation is normal. Trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms & conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)